Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

2011 Criminal and Civil Investigations Settlement

In November 2011, GlaxoSmithKline announced it would set aside $3 billion to resolve criminal and civil investigations into marketing practices with regard to its Avandia diabetes drug, a Department of Justice investigation of its Medicaid pricing practices, and a nationwide investigation into the sales and marketing of nine of its products from 1997 to 2004. Under the settlement, the terms of which were finalized in 2012, GSK agreed to pay $3 billion in fines and penalties and plead guilty to three criminal counts. GSK also executed a five-year corporate integrity agreement with the Department of Health and Human Services, Office of Inspector General (HHS-OIG) requiring GSK to implement major changes to the way it compensates its sales force and to implement greater transparency in its research practices and publication policies.

Misconduct Type
Health
Enforcement Agency
Multiple Agencies
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
11/3/2011
Contractors Involved Penalty
Total
GlaxoSmithKline $3,000,000,000

Federal Contractor Misconduct Database